Friday, February 20, 2026

Bayer Soars After $10.5 Billion Settlement On Current And Future Roundup Cancer Lawsuits






I must say that when Bayer acquired MonsNTO  a mere seven years ago, that i thought that they were insane or knew something that I did not.  So far the insanity judgement holds.  ten billion serttlements are no joke  for an 84 billion acquisition.    

in the meantime this settles pre merger suits i am sure ,but leaves the door open for ongoing suits. Nasty.

understand that roundup is clearly valuable.  However, its application is dangerous and must be MANAGED.  sprayig this willy nilly and breathing in fumes is obviously dumb but also plausibly unavoidable without a sealed tractor cabin.

Yet no better fix exists for neutralizing a seedbed once.  Using this to dehydrate ripe wheat is convenience vover common sense.  Today consumers are banning roundup residues.  And yes, they should. 

what this emphasizes is that both DDT and Roundup have a valid apllication space because they are firstly effective ,but that also makes them dangertous.  This applies to almost all insecticides as well.

I hate to say this, but broad spraying should likely be banned except for benign agents susch as soap.  The nasties can be restricted to human eyeball application.



Bayer Soars After $10.5 Billion Settlement On Current And Future Roundup Cancer Lawsuits

Tuesday, Feb 17, 2026 - 09:20 AM

https://www.zerohedge.com/markets/bayer-soars-after-105-billion-settlement-current-and-future-roundup-cancer-lawsuits

Bayer stock jumped the most in three months after the company announced a $10.5 billion settlement push to settle current and future cancer lawsuits over its Roundup weedkiller. The news was first reported by Bloomberg.

The German chemical giant proposed a $7.5 billion class-action settlement through cases filed in state court in Missouri designed to resolve Roundup suits that already have been filed and potential claims that could be filed over a 20-year period.

Bayer also announced $3 billion in settlements of existing U.S. cases in which former Roundup users blame the herbicide for causing their non-Hodgkins lymphoma, it reported.

The company has paid about $10 billion to settle most of the Roundup lawsuits that were pending as of 2020, but failed to get a settlement covering future cases. New lawsuits have continued to pour in since then. Plaintiffs have said they developed non-Hodgkin's lymphoma and other forms of cancer due to using Roundup, either at home or on the job.

Roundup, which was acquired by Bayer, is among the most widely used weedkillers in the United States

The class settlement aimed at resolving current and future claims that Roundup weedkiller caused non‑Hodgkin lymphoma is an important addition to its Supreme Court case, Bayer CEO Bill Anderson said on Tuesday.

"We are entering into the settlement because it is an important addition to the case before the Supreme Court, thereby minimising the legal risks as comprehensively as possible," he said. "Both elements are necessary independently of each other and reinforce each other," he added.

Bayer stock surged on news of the settlement.

No comments: